Biopharma engineering company-Fabtech Technologies Ltd, get listed on BSE & NSE Today

On Tuesday, shares of Fabtech Technologies Ltd got listed on BSE at Rs 191 per share and on NSE at Rs 192 per share while the IPO price was Rs 191 per share.

The Fabtech Technologies Ltd IPO raised Rs 230.35 crore, which consisted entirely of a fresh issue of 1.21 crore shares. The biopharma engineering company, incorporated in 2018, set the IPO upper price band at Rs 191 per share. Retail investors were required to invest a minimum of Rs 14,325 for a lot size of 75 shares at the upper price band. The company also reserved up to 54,945 shares for eligible employees, who were offered a discount of Rs 9 per share on the issue price.

The public subscription window for the issue opened on September 29, 2025, and concluded on October 1, 2025. Demand for the issue was moderate, as the IPO was subscribed 2.03 times in total. The Retail Individual Investors (RIIs) category was booked 2.08 times, while the Non-Institutional Investors (NII) and Qualified Institutional Buyers (QIBs) segments saw subscriptions of 1.97 times and 2.02 times, respectively. The company intended to utilise the net proceeds from the issue primarily for funding working capital needs, pursuing inorganic growth initiatives, and for general corporate purposes.

The finalisation of the share allotment for the Fabtech Technologies IPO occurred on October 3, 2025. The shares subsequently made their debut on the stock exchanges, BSE and NSE, on October 7, 2025. On listing, the company commanded a market capitalisation of approximately Rs 849 crore. The company's financial performance leading up to the IPO was robust, with revenue increasing by 46 per cent and profit after Tax (PAT) rising by 70 per cent between the financial years ending March 31, 2024 and March 31, 2025.

Disclaimer: The article is for informational purposes only and not investment advice.